LNK-deficient mice exhibit a mild, chronic myeloid leukemia (CML)-like phenotype [68], demonstrating how acquisition of additional mutations can modulate disease progression (Table 3). The gene discussed is SH2B3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.